‘Cybin is the only green stock in my portfolio’ – r/shroomstocks Cybin (CYBN.NE) started out June 1st at $1.71 CAD and has since launched up to $2.72, a 60%…
shroom stocks 2021
Steady as she goes It’s been a rough couple of quarters for the psychedelics sector at large. Some companies have been able to avoid the correction, but for the…
Brain trauma/CTE Lobe Sciences (LOBE.C) is working to develop effective psychedelic-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder with a focus on contact…
Last week Cybin (CYBN.NE) announced it was targetting alcoholism with its novel psychedelic compound CYB003. Another EG staffer wrote a piece last Monday outlining the details of the plan,…
Nova Mentis (NOVA.C) is on a mission to incorporate psychedelics in treating chronic inflammatory conditions like autism spectrum disorder (ASD), fragile X syndrome (FXS), epilepsy, traumatic brain injury, multiple…
Supersized bought deal Field Trip (FTRP.CN) announced on Friday that it raised a whopping $95.3M CAD through a bought deal. The deal was originally for proceeds of $50M CAD…
Cut the kumbaya shit Throwing the words profit and psychedelic drugs into a sentence would have lead to awkward and confused looks 5 years ago. But we have come…